Emerging therapies for fibromyalgia

Jacob N. Ablin, Dan Buskila

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Background: Fibromyalgia syndrome (FMS) is a disorder characterized by widespread pain, tenderness, and fatigue. High prevalence marks the syndrome which is considered to reflect altered central pain processing. Fibromyalgia syndrome runs a chronic, non-progressive course, extracting high price owing to impaired quality of life, restricted vocational capacity, and increased health care utilization. Objective: To review current and emerging trends in the treatment of FMS. Methods: A rigorous search of published literature, abstract presentations, and industry provided data was performed. Results/conclusion: The recent FDA approval of pregabalin as a first specific medication for FMS may herald a new era for the development of medications with higher specificity and efficacy for this hitherto frustrating condition.

Original languageEnglish
Pages (from-to)53-62
Number of pages10
JournalExpert Opinion on Emerging Drugs
Issue number1
StatePublished - 1 Mar 2008
Externally publishedYes


  • Dopamine agonists
  • Fibromyalgia
  • Growth hormone
  • Melatonin
  • Reuptake inhibitors
  • αδ ligands

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Emerging therapies for fibromyalgia'. Together they form a unique fingerprint.

Cite this